Search results
Brokerages Set Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Target Price at $26.56
ETF DAILY NEWS· 5 days agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the company ...